Allomaron

Allomaron Medicine

Contraindications

Hypersensitivity, hemochromatosis, severe renal impairment (with serum creatinine levels above 132.6 µmol / L (1.5 mg / 100 ml) or with glomerular filtration rate below 40 ml / min), pregnancy, breastfeeding, age (under 14 years).

Incompatibilities

Increases the toxicity of azathioprine and mercaptopurine, the anticoagulant effect of coumarin derivatives, prolongs the effect of chlorpropamide, thiazide diuretics, etacrine and salicylic acid derivatives reduce the effect (increase the level of uric acid in the serum). When treated with iron preparations, it increases the accumulation of iron in the liver.

Undesirable effects

Gastrointestinal disorders, diarrhea, vasculitis with skin manifestations and fever, liver and kidney damage, changes in the blood picture (leukopenia, thrombocytopenia), allergic reactions.

Therapeutic indications

Hyperuricemia of various origins, gout.

Pharmacotherapeutic group

  • Agents that affect the metabolism of uric acid

Special precautions for storage

At room temperature.

Keep out of reach of children.

Shelf life of the drug Allomaron®5 лет.

Do not use after the expiration date indicated on the package.

Nature and contents of container

1 tablet, coated, contains allopurinol 100 mg and benzbromarone 20 mg, in a blister of 20 pcs.

Nosological classification (ICD-10)

  • E79. 0 Hyperuricemia without signs of inflammatory arthritis and gout nodes
  • M10 Gout

Dosage (Posology) and method of administration

Inside, 1-3 tables. on the day after meals, with the obligatory use of at least 1.5-2 liters of liquid per day (under the control of diuresis). Treatment should begin with 1 table. daily with a gradual increase in the dose.

ATC - Anatomical and therapeutic chemical classification

M04AA51 Allopurinol in combination with other drugs